ConductScience.org, home

Paper37322012

Primary central nervous system lymphoma.

Ferreri AJM and 10 others. Nat Rev Dis Primers, 2023. Cited by 214 papers, by iCite.

Cite this record

ConductScience Library. Primary central nervous system lymphoma. Papers, record 37322012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37322012

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Primary central nervous system lymphoma.
PubMed
Journal
Nat Rev Dis Primers
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
214
iCite
Relative citation ratio, by iCite
22.5
iCite
Revised in PubMed
2025-12-03
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ferreri AJMAndrés J M
2Calimeri TTeresa
3Cwynarski KKate
4Dietrich JJorghttps://orcid.org/0000-0001-8291-0136
5Grommes CChristian
6Hoang-Xuan KKhê
7Hu LSLeland S
8Illerhaus GGeraldhttps://orcid.org/0000-0002-0009-8138
9Nayak LLakshmi
10Ponzoni MMaurilio
11Batchelor TTTracy T

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hematopoietic Stem Cell TransplantationMajor topic
Central Nervous System NeoplasmsMajor topic
LymphomaMajor topic
Humans
Aged
Combined Modality Therapy
Endothelial Cells
Transplantation, Autologous
Neoplasm Recurrence, Local
Brain

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P30 CA008748NCI NIH HHSUnited StatesP30CA008748PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References216

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129713087Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018https://conductscience.org/library/papers/29713087PubMed
214592832Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation.Blood2004https://conductscience.org/library/papers/14592832PubMed
328982883Programmed Cell Death Ligand 1 Expression in Primary Central Nervous System Lymphomas: A Clinicopathological Study.Anticancer Res2017https://conductscience.org/library/papers/28982883PubMed
412525518Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience.J Clin Oncol2003https://conductscience.org/library/papers/12525518PubMed
515653703High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma.Ann Oncol2005https://conductscience.org/library/papers/15653703PubMed
624061549
Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYC(low)BCL2 (low) subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas.
Acta Neuropathol2013https://conductscience.org/library/papers/24061549PubMed
719494841Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma.Leukemia2009https://conductscience.org/library/papers/19494841PubMed
824105672Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant.Cancer2013https://conductscience.org/library/papers/24105672PubMed
925189415The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing.Leukemia2015https://conductscience.org/library/papers/25189415PubMed
1035732829The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.Leukemia2022https://conductscience.org/library/papers/35732829PubMed
1132026432Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma.J Neurooncol2020https://conductscience.org/library/papers/32026432PubMed
1234063335Breaching the Blood-Brain Tumor Barrier for Tumor Therapy.Cancers (Basel)2021https://conductscience.org/library/papers/34063335PubMed
1331925841Expression of the ghrelin/growth hormone secretagogue receptor axis and its functional role in promoting tumor growth in primary central nervous system lymphomas.Neuropathology2020https://conductscience.org/library/papers/31925841PubMed
1419767089High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.Lancet2009https://conductscience.org/library/papers/19767089PubMed
1523721553Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era.Am J Transplant2013https://conductscience.org/library/papers/23721553PubMed
1626757737Genomic characterization of primary central nervous system lymphoma.Acta Neuropathol2016https://conductscience.org/library/papers/26757737PubMed
1731886867Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma.J Neuropathol Exp Neurol2020https://conductscience.org/library/papers/31886867PubMed
1815232310Pseudouveitis: a clue to the diagnosis of primary central nervous system lymphoma in immunocompetent patients.Medicine (Baltimore)2004https://conductscience.org/library/papers/15232310PubMed
1929054815
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.
Lancet Haematol2017https://conductscience.org/library/papers/29054815PubMed
2031869415Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents.Blood Adv2019https://conductscience.org/library/papers/31869415PubMed

See all 216 referencesDownload CSV of references

Cited by166

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 214 citations.

PMIDTitleJournalYearIn PapersSource
42983653Validation of the "purfling sign" for differentiating primary central nervous system lymphoma from high-grade glioma: a retrospective multicenter cohort study.BMC Med Imaging2026https://conductscience.org/library/papers/42983653PubMed
42977864Pediatric suprasellar primary CNS lymphoma with cavernous sinus invasion and ischemic stroke: a case report and systematic review.Childs Nerv Syst2026https://conductscience.org/library/papers/42977864PubMed
42965234Anaplastic Large Cell Lymphoma of the Brain Mimicking an Extra-Axial Frontal Tumor: A Case Report.Cureus2026https://conductscience.org/library/papers/42965234PubMed
42938799Vitreoretinal Lymphoma: From Pathobiology to Integrated Diagnosis.Cancers (Basel)2026https://conductscience.org/library/papers/42938799PubMed
42931981Bilateral hearing impairment as an unusual symptom of primary central nervous system lymphoma: a presumed central auditory presentation in a young immunocompetent patient.Neurol Sci2026https://conductscience.org/library/papers/42931981PubMed
42910270Efficacy and Safety of an Orelabrutinib-Based Oral Induction Regimen in Central Nervous System Lymphoma: A Real-World Study.Blood Lymphat Cancer2026https://conductscience.org/library/papers/42910270PubMed
42830763IMiD-based monotherapy for maintenance of remission in primary CNS lymphoma: a single-center experience.Blood Neoplasia2026https://conductscience.org/library/papers/42830763PubMed
42823715Advances in molecular pathobiology of PCNSL - towards clinical implementation of novel diagnostics and therapeutics.Biomark Res2026https://conductscience.org/library/papers/42823715PubMed
42814177Primary central nervous system lymphoma in the molecular era: genomic drivers, liquid biopsy, and targeted therapeutic strategies.Ann Hematol2026https://conductscience.org/library/papers/42814177PubMed
42811343Genetic orchestration of the primary central nervous system lymphoma microenvironment.Biomark Res2026https://conductscience.org/library/papers/42811343PubMed
42793717Spectrum of Neuroimaging Findings in CNS Lymphoproliferative Disorders.Diagnostics (Basel)2026https://conductscience.org/library/papers/42793717PubMed
42741313Efficacy and safety of rituximab in the treatment of primary central nervous system lymphoma: A meta-analysis and systematic review of 1,388 patients.Oncol Lett2026https://conductscience.org/library/papers/42741313PubMed
42682662Case Report: Rare brainstem involvement in anti-metabotropic glutamate receptor 1 encephalitis.Front Immunol2026https://conductscience.org/library/papers/42682662PubMed
42668694Spatial pattern-driven interpretable model and biological correlates in brain glioblastoma-lymphoma differentiation.iScience2026https://conductscience.org/library/papers/42668694PubMed
42609866No association between temozolomide maintenance and survival after first-line treatment in primary CNS lymphoma.Hemasphere2026https://conductscience.org/library/papers/42609866PubMed
42592300Design, preclinical evaluation, and multicenter phase 1 clinical study of HZ-A-018 for relapsed or refractory central nervous system lymphoma.Acta Pharm Sin B2026https://conductscience.org/library/papers/42592300PubMed
42564765CNS involvement by EBV-positive extranodal T-cell lymphoma harboring STAT3 Y640F mutation following allogeneic hematopoietic stem cell transplantation: A case report.Radiol Case Rep2026https://conductscience.org/library/papers/42564765PubMed
42473159Case Report: Primary Central Nervous System Lymphoma With "Wine Glass" Sign Presenting as Somnolence and Fatigue.Am J Case Rep2026https://conductscience.org/library/papers/42473159PubMed
42430569
Intensified Rituximab, Methotrexate, Procarbazine, and Cytarabine (R-MPVA) Regimen With Sequential Addition of Etoposide to R-MPV and Ifosfamide to R-AraC for Newly Diagnosed Primary CNS Lymphoma Patients Aged Between 60 and 70 Years: An LOC Network Study.
Hematol Oncol2026https://conductscience.org/library/papers/42430569PubMed
42428147MRI biomarkers of primary CNS lymphoma outcome after MATRix: real world performance.Front Oncol2026https://conductscience.org/library/papers/42428147PubMed

See all 166 cited byDownload CSV of cited by

Genes85

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADAP255803PubTator's text mininghttps://conductscience.org/library/genes/55803NCBI Gene
AQP4361PubTator's text mininghttps://conductscience.org/library/genes/361NCBI Gene
B2M567PubTator's text mininghttps://conductscience.org/library/genes/567NCBI Gene
BAIAP210458PubTator's text mininghttps://conductscience.org/library/genes/10458NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL6604PubTator's text mininghttps://conductscience.org/library/genes/604NCBI Gene
BTG27832PubTator's text mininghttps://conductscience.org/library/genes/7832NCBI Gene
BTK695PubTator's text mininghttps://conductscience.org/library/genes/695NCBI Gene
CARD1184433PubTator's text mininghttps://conductscience.org/library/genes/84433NCBI Gene
CD1639332PubTator's text mininghttps://conductscience.org/library/genes/9332NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD58965PubTator's text mininghttps://conductscience.org/library/genes/965NCBI Gene
CD68968PubTator's text mininghttps://conductscience.org/library/genes/968NCBI Gene
CD69969PubTator's text mininghttps://conductscience.org/library/genes/969NCBI Gene
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973NCBI Gene
CD79B974PubTator's text mininghttps://conductscience.org/library/genes/974NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CDKN2A1029PubTator's text mininghttps://conductscience.org/library/genes/1029NCBI Gene
CIITA4261PubTator's text mininghttps://conductscience.org/library/genes/4261NCBI Gene

See all 85 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37322012

GET https://conductscience.org/api/papers/v1/37322012/references?page=2